{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:37:22Z","timestamp":1789706242521,"version":"4.0.1"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10787-026-02156-y","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:12:40Z","timestamp":1775113960000},"page":"3193-3207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Repurposing of doxycycline as a novel therapeutic avenue for management of parkinson\u2019s disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Naif H.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar R.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5988-6883","authenticated-orcid":false,"given":"Tasnim S.","family":"Waheeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2156_CR1","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1167\/iovs.07-0947","volume":"49","author":"T Abe","year":"2008","unstructured":"Abe T, Wakusawa R, Seto H, Asai N, Saito T, Nishida K (2008) Topical doxycycline can induce expression of bdnf in transduced retinal pigment epithelial cells transplanted into the subretinal space. Invest Ophthalmol vis Sci 49:3631\u20133639","journal-title":"Invest Ophthalmol vis Sci"},{"key":"2156_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01779-7","volume":"29","author":"B Alharbi","year":"2024","unstructured":"Alharbi B, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Alharbi H, Alexiou A, Papadakis M, Batiha GE-S (2024) Role of GABA pathway in motor and non-motor symptoms in Parkinson\u2019s disease: a bidirectional circuit. Eur J Med Res 29:205","journal-title":"Eur J Med Res"},{"key":"2156_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18368","volume":"28","author":"NH Ali","year":"2024","unstructured":"Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, AlAseeri AA, Alruwaili M, Saad HM, Batiha GE (2024a) BDNF\/TrkB activators in Parkinson\u2019s disease: a new therapeutic strategy. J Cell Mol Med 28:e18368","journal-title":"J Cell Mol Med"},{"key":"2156_CR4","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s12035-023-03727-8","volume":"61","author":"NH Ali","year":"2024","unstructured":"Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alnaaim SA, Saad HM, Batiha GE (2024b) The molecular pathway of p75 neurotrophin receptor (p75NTR) in Parkinson\u2019s disease: the way of new inroads. Mol Neurobiol 61:2469\u20132480","journal-title":"Mol Neurobiol"},{"key":"2156_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/2008-7802.184314","volume":"7","author":"HM Al-Kuraishy","year":"2016","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2016) Potential effects of Pomegranate on lipid peroxidation and pro-inflammatory changes in Daunorubicin-induced cardiotoxicity in rats. Int J Prev Med 7:85","journal-title":"Int J Prev Med"},{"key":"2156_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/ijpvm.IJPVM_5_19","volume":"10","author":"HM Al-Kuraishy","year":"2019","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Nami MS (2019a) Vinpocetine improves oxidative stress and pro-inflammatory mediators in acute kidney injury. Int J Prev Med 10:142","journal-title":"Int J Prev Med"},{"key":"2156_CR7","first-page":"e95563","volume":"14","author":"HM Al-Kuraishy","year":"2019","unstructured":"Al-Kuraishy HM, Al-Kuraishi AH, Al-Windy S, Al-Gareeb AI (2019b) Toxoplasmosis and risk of endothelial dysfunction: role of oxidative stress and pro-inflammatory mediators. Arch Clin Infect Dis 14:e95563","journal-title":"Arch Clin Infect Dis"},{"key":"2156_CR8","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.IJPVM_567_18","volume":"11","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Nami MS (2020) Irbesartan attenuates Gentamicin-induced nephrotoxicity in rats through modulation of oxidative stress and endogenous antioxidant capacity. Int J Prev Med 11:16","journal-title":"Int J Prev Med"},{"issue":"8","key":"2156_CR9","doi-asserted-by":"publisher","first-page":"642181","DOI":"10.3389\/fcvm.2021.642181","volume":"17","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Abdullah SM, Cruz-Martins N, Batiha GE (2021a) Case report: hyperbilirubinemia in gilbert syndrome attenuates Covid-19-induced metabolic disturbances. Front Cardiovasc Med 17(8):642181","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"2156_CR10","doi-asserted-by":"publisher","first-page":"642822","DOI":"10.3389\/fphar.2021.642822","volume":"23","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alqarni M, Cruz-Martins N, El-Saber BG (2021b) Pleiotropic effects of tetracyclines in the management of COVID-19: emerging perspectives. Front Pharmacol 23(12):642822","journal-title":"Front Pharmacol"},{"issue":"67","key":"2156_CR11","doi-asserted-by":"publisher","first-page":"102008","DOI":"10.1016\/j.pupt.2021.102008","volume":"1","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Qusty N, Cruz-Martins N, Batiha GE (2021c) Sequential doxycycline and colchicine combination therapy in Covid-19: the salutary effects. Pulm Pharmacol Therap 1(67):102008","journal-title":"Pulm Pharmacol Therap"},{"key":"2156_CR12","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s10753-022-01648-7","volume":"45","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Niemi MS, Aljowaie RM, Almutairi SM, Alexiou A, Batiha GE (2022a) The prospective effect of Allopurinol on the oxidative stress index and endothelial dysfunction in Covid-19. Inflammation 45:1651\u20131667","journal-title":"Inflammation"},{"issue":"47","key":"2156_CR13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.clnesp.2021.12.030","volume":"1","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Batiha GE (2022b) The possible role of ursolic acid in Covid-19: a real game changer. Clin Nutr ESPEN. 1(47):414\u2013417","journal-title":"Clin Nutr ESPEN."},{"key":"2156_CR14","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s10571-023-01350-8","volume":"43","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Elewa YHA, Zahran MH, Alexiou A, Papadakis M, Batiha GE-S (2023a) Parkinson\u2019s disease risk and hyperhomocysteinemia: the possible link. Cell Mol Neurobiol 43:2743\u20132759","journal-title":"Cell Mol Neurobiol"},{"key":"2156_CR160","doi-asserted-by":"crossref","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Alsayegh AA, Almohmadi NH, Saad HM, Batiha GE (2023c) Pros and cons for statins use and risk of Parkinson\u2019s disease: an updated perspective. Pharmacol Res Perspect 11(2):e01063","DOI":"10.1002\/prp2.1063"},{"key":"2156_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102075","volume":"91","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Jabir MS, Al-Gareeb AI, Albuhadily AK (2023b) The conceivable role of prolactin hormone in Parkinson disease: the same goal but with different ways. Ageing Res Rev 91:102075","journal-title":"Ageing Res Rev"},{"key":"2156_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00210-023-02656-6","volume":"397","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Selim HM, Alexiou A, Papadakis M, Negm WA, Batiha GE-S (2024a) Does vitamin D protect or treat Parkinson\u2019s disease? A narrative review. Naunyn Schmiedebergs Arch Pharmacol 397:33\u201340","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2156_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102143","volume":"93","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Zaidalkiani AT, Alexiou A, Papadakis M, Bahaa MM, Al-Faraga A, Batiha GE (2024b) Calprotectin in Parkinsonian disease: anticipation and dedication. Ageing Res Rev 93:102143","journal-title":"Ageing Res Rev"},{"key":"2156_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102200","volume":"94","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Al-Hamash SM, Jabir MS, Al-Gareeb AI, Albuhadily AK, Albukhaty S, Sulaiman GM (2024c) The classical and non-classical axes of renin-angiotensin system in Parkinson disease: the bright and dark side of the moon. Ageing Res Rev 94:102200","journal-title":"Ageing Res Rev"},{"key":"2156_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10787-023-01400-z","volume":"32","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Fahad EH, Al-Windy S, El-Sherbeni SA, Negm WA, Batiha GE-S (2024d) The effects of cholesterol and statins on Parkinson\u2019s neuropathology: a narrative review. Inflammopharmacol 32:917\u2013925","journal-title":"Inflammopharmacol"},{"key":"2156_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102209","volume":"95","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Jabir MS, Al-Gareeb AI, Albuhadily AK (2024e) New insight on the possible role of statins in Vascular Parkinsonism: a need for presumptive therapy. Ageing Res Rev 95:102209","journal-title":"Ageing Res Rev"},{"key":"2156_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102684","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Al Ali A, Abu-Alghayth MH (2025a) Beyond amyloid plaque, targeting \u03b1-synuclein in Alzheimer disease: the battle continues. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2025.102684","journal-title":"Ageing Res Rev"},{"key":"2156_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1494101","volume":"12","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Mohammed SG, Al-Gareeb AI, Albuhadily AK, Dawood RA, Al Ali A, Abu-Alghayth MH (2025b) Amyloid-\u03b2 and heart failure in Alzheimer\u2019s disease: the new vistas. Front Med (Lausanne) 12:1494101","journal-title":"Front Med (Lausanne)"},{"key":"2156_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05098-8","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM, Sulaiman GM, Saad HM, Mohammed HA, Abomughaid MM, Al-Gareeb AI, Albuhadily AK (2025c) The effect of metformin on astrocytes in Parkinson\u2019s disease: challenges and opportunities. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05098-8","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2156_CR24","doi-asserted-by":"publisher","first-page":"e01063","DOI":"10.1002\/prp2.1063","volume":"11","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Alsayegh AA, Almohmadi NH, Saad HM, Batiha GE (2023a) Pros and cons for statins use and risk of Parkinson\u2019s disease: an updated perspective. Pharmacol Res Perspect 11(2):e01063","journal-title":"Pharmacol Res Perspect"},{"key":"2156_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jnr.25171","volume":"101","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Ahmed EA, Batiha GES (2023b) SARS-COV-2 infection and Parkinson\u2019s disease: possible links and perspectives. J Neurosci Res 101:952\u2013975","journal-title":"J Neurosci Res"},{"key":"2156_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70167","volume":"30","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Albukhaty S, Albuhadily AK, Al-Gareeb AI, Klionsky DJ, Abomughaid MM (2024) The compelling role of brain-derived neurotrophic factor signaling in multiple sclerosis: role of BDNF activators. CNS Neurosci Ther 30:e70167","journal-title":"CNS Neurosci Ther"},{"key":"2156_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102810","volume":"110","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM, Al-Maiahy TJ, Sulaiman GM, Mohammed HA, Albuhadily AK, Al-Gareeb AI, Abomughaid MM (2025a) The potential role of aryl hydrocarbon receptor in Alzheimer\u2019s disease: protective or detrimental. Ageing Res Rev 110:102810","journal-title":"Ageing Res Rev"},{"key":"2156_CR28","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s10787-025-01796-w","volume":"33","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Saad HM, Al-Gareeb AI, Albuhadily AK (2025b) Targeting the JAK\/STAT3\/SOCS signaling pathway in Alzheimer\u2019s disease. Inflammopharmacol 33:2951\u20132962","journal-title":"Inflammopharmacol"},{"key":"2156_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12035-023-03561-y","volume":"61","author":"SA Alnaaim","year":"2024","unstructured":"Alnaaim SA, Al-Kuraishy HM, Alexiou A, Papadakis M, Saad HM, Batiha GE-S (2024) Role of brain liver X receptor in Parkinson\u2019s disease: hidden treasure and emerging opportunities. Mol Neurobiol 61:341\u2013357","journal-title":"Mol Neurobiol"},{"key":"2156_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111338","volume":"226","author":"H Alnoaman","year":"2025","unstructured":"Alnoaman H, Al-Kuraishy HM, Al-Gareeb AI, Turkistani A, Allam A, Alexiou A, Papadakis M, Batiha GE-S (2025) Dysregulation of proBDNF\/p75NTR and BDNF\/TrkB signaling in acute ischemic stroke: different sides of the same coins. Brain Res Bull 226:111338","journal-title":"Brain Res Bull"},{"key":"2156_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18495","volume":"28","author":"Z Al-Qahtani","year":"2024","unstructured":"Al-Qahtani Z, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Ali NH, Alexiou A, Papadakis M, Saad HM, Batiha GES (2024) The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat? J Cell Mol Med 28:e18495","journal-title":"J Cell Mol Med"},{"key":"2156_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12017-025-08857-x","volume":"27","author":"SM Alqahtani","year":"2025","unstructured":"Alqahtani SM, Al-Kuraishy HM, Al Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, Hemeda LR, Faheem SA, El-Saber Batiha G (2025) Unlocking Alzheimer\u2019s disease: the role of BDNF signaling in neuropathology and treatment. Neuromol Med 27:36","journal-title":"Neuromol Med"},{"key":"2156_CR33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10787-023-01192-2","volume":"31","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE-S (2023a) A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson\u2019s disease: beneficial or detrimental effects. Inflammopharmacol 31:673\u2013688","journal-title":"Inflammopharmacol"},{"key":"2156_CR34","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1007\/s11033-023-08459-5","volume":"50","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Zaafar D, Batiha GE-S (2023b) Orexin pathway in Parkinson\u2019s disease: a review. Mol Biol Rep 50:6107\u20136120","journal-title":"Mol Biol Rep"},{"key":"2156_CR35","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1007\/s10072-023-06926-2","volume":"44","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Mahammadawy A-kAA, Al-Gareeb AI, Saad HM, Batiha GE-S (2023c) The potential role of cholesterol in Parkinson\u2019s disease neuropathology: perpetrator or victim. Neurol Sci 44:3781\u20133794","journal-title":"Neurol Sci"},{"key":"2156_CR36","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/jcmm.17784","volume":"27","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Jabir MS, Saad HM, Batiha GES (2023d) NF-\u03baB\/NLRP3 inflammasome axis and risk of Parkinson\u2019s disease in type 2 diabetes mellitus: a narrative review and new perspective. J Cell Mol Med 27:1775\u20131789","journal-title":"J Cell Mol Med"},{"key":"2156_CR37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/npr2.12445","volume":"44","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alshammari MS, Alexiou A, Papadakis M, Bahaa MM, Batiha GE (2024a) Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: a new perspective. Neuropsychopharmacol Rep 44:639\u2013649","journal-title":"Neuropsychopharmacol Rep"},{"key":"2156_CR38","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","volume":"479","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Ashour NA, Jabir MS, Negm WA, Batiha GE-S (2024b) Metformin role in Parkinson\u2019s disease: a double-sword effect. Mol Cell Biochem 479:975\u2013991","journal-title":"Mol Cell Biochem"},{"key":"2156_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11064-023-04064-x","volume":"49","author":"R AlRuwaili","year":"2024","unstructured":"AlRuwaili R, Al-Kuraishy HM, Al-Gareeb AI, Ali NH, Alexiou A, Papadakis M, Saad HM, Batiha GE (2024) The possible role of brain-derived neurotrophic factor in epilepsy. Neurochem Res 49:533\u2013547","journal-title":"Neurochem Res"},{"key":"2156_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2025.156983","volume":"193","author":"SM Alshahrani","year":"2025","unstructured":"Alshahrani SM, Al-Kuraishy HM, Albuhadily AK, Al-Gareeb AI, Abdelaziz AM, Alexiou A, Papadakis M, Alruwaili M, Batiha GE-S (2025) GDF15 upregulation in Parkinson\u2019s disease: compensatory mechanisms and causal insights. Cytokine 193:156983","journal-title":"Cytokine"},{"key":"2156_CR162","doi-asserted-by":"publisher","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M, Fekete R (2021) Intestinal decontamination therapy for dyskinesia and motor fluctuations in Parkinson\u2019s disease. Front Neurol 12:729961. https:\/\/doi.org\/10.3389\/fneur.2021.729961","DOI":"10.3389\/fneur.2021.729961"},{"key":"2156_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00738","volume":"10","author":"C Balducci","year":"2019","unstructured":"Balducci C, Forloni G (2019) Doxycycline for Alzheimer\u2019s disease: fighting \u03b2-amyloid oligomers and neuroinflammation. Front Pharmacol 10:738","journal-title":"Front Pharmacol"},{"key":"2156_CR42","doi-asserted-by":"crossref","unstructured":"Bhardwaj I, Ansari AH, Singh S, Singh D, Pratap R (2021) Significance of 3D organoid models in Neurodegenerative diseases. In: Neurodegenerative diseases, 1st edn. CRC Press, pp 147\u2013155","DOI":"10.1201\/9781032620442-12"},{"key":"2156_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/biom14030320","author":"S Bhattacharjya","year":"2024","unstructured":"Bhattacharjya S, Zhang Z, Ramamoorthy A (2024) LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases. Biomolecules. https:\/\/doi.org\/10.3390\/biom14030320","journal-title":"Biomolecules"},{"key":"2156_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnana.2015.00091","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson\u2019s disease. Front Neuroanat 9:91","journal-title":"Front Neuroanat"},{"issue":"10","key":"2156_CR45","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00702-018-1913-1","volume":"125","author":"M Bortolanza","year":"2018","unstructured":"Bortolanza M, Nascimento GC, Socias SB, Ploper D, Cheh\u00edn RN, Raisman-Vozari R, Del-Bel E (2018) Tetracycline repurposing in neurodegeneration: focus on Parkinson\u2019s disease. J Neural Transm (Vienna, Austria: 1996) 125(10):1403\u20131415","journal-title":"J Neural Transm (Vienna, Austria: 1996)"},{"key":"2156_CR46","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1111\/bph.15439","volume":"178","author":"M Bortolanza","year":"2021","unstructured":"Bortolanza M, do Nascimento GC, Raisman-Vozari R, Del-Bel E (2021) Doxycycline and its derivative, COL-3, decrease dyskinesia induced by l-DOPA in hemiparkinsonian rats. Br J Pharmacol 178:2595\u20132616","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2156_CR47","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s13104-017-2960-7","volume":"10","author":"FD Boynton","year":"2017","unstructured":"Boynton FD, Ericsson AC, Uchihashi M, Dunbar ML, Wilkinson JE (2017) Doxycycline induces dysbiosis in female C57BL\/6NCrl mice. BMC Res Notes 10(1):644","journal-title":"BMC Res Notes"},{"key":"2156_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060726","author":"F Bruno","year":"2022","unstructured":"Bruno F, Malvaso A, Canterini S, Bruni AC (2022) Antimicrobial peptides (AMPs) in the pathogenesis of Alzheimer\u2019s disease: implications for diagnosis and treatment. Cells. https:\/\/doi.org\/10.3390\/antibiotics11060726","journal-title":"Cells"},{"key":"2156_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.14336\/AD.2015.0825","volume":"6","author":"J Budni","year":"2015","unstructured":"Budni J, Bellettini-Santos T, Mina F, Garcez ML, Zugno AI (2015) The involvement of BDNF, NGF and GDNF in aging and Alzheimer\u2019s disease. Aging Dis 6:331\u2013341","journal-title":"Aging Dis"},{"key":"2156_CR50","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/brain\/awad150","volume":"146","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Di Lazzaro G, Marino G, Campanelli F, Ghiglieri V (2023) Advances in understanding the function of alpha-synuclein: implications for Parkinson\u2019s disease. Brain 146:3587\u20133597","journal-title":"Brain"},{"key":"2156_CR51","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.phrs.2011.04.002","volume":"64","author":"MM Castro","year":"2011","unstructured":"Castro MM, Tanus-Santos JE, Gerlach RF (2011) Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension. Pharmacol Res 64:567\u2013572","journal-title":"Pharmacol Res"},{"key":"2156_CR52","first-page":"955","volume":"12","author":"S Chakrabarti","year":"2023","unstructured":"Chakrabarti S, Bisaglia M (2023) Oxidative stress and neuroinflammation in Parkinson\u2019s disease: the role of dopamine oxidation products. Antioxidants (Basel, Switzerland) 12:955","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"2156_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2251","volume":"11","author":"E Chang","year":"2021","unstructured":"Chang E, Wang J (2021) Brain-derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson\u2019s disease. Brain Behav 11:e2251","journal-title":"Brain Behav"},{"key":"2156_CR54","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3390\/ani11072047","volume":"11","author":"RJ Chapuis","year":"2021","unstructured":"Chapuis RJ, Smith JS, French HM, Toka FN, Peterson EW, Little EL (2021) Nonlinear mixed-effect pharmacokinetic modeling and distribution of doxycycline in healthy female donkeys after multiple intragastric dosing\u2013preliminary investigation. Animals 11:2047","journal-title":"Animals"},{"key":"2156_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.euroneuro.2020.11.007","volume":"42","author":"AJM Chaves Filho","year":"2021","unstructured":"Chaves Filho AJM, Cunha NL, Rodrigues PA, de Souza AG, Soares MV, Juc\u00e1 PM, de Queiroz T, Clemente D, Mottin M, Andrade CH, Peixoto CA, Macedo DS (2021) Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment? Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 42:57\u201374","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"2156_CR56","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1038\/s41380-022-01790-6","volume":"27","author":"X Chen","year":"2022","unstructured":"Chen X, Deng S, Wang W, Castiglione S, Duan Z, Luo L, Cianci F, Zhang X, Xu J, Li H, Zhao J, Kamau PM, Zhang Z, Mwangi J, Li J, Shu Y, Hu X, Mazzanti M, Lai R (2022) Human antimicrobial peptide LL-37 contributes to Alzheimer\u2019s disease progression. Mol Psychiatry 27:4790\u20134799","journal-title":"Mol Psychiatry"},{"key":"2156_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113236","volume":"10","author":"N Chiarelli","year":"2021","unstructured":"Chiarelli N, Zoppi N, Venturini M, Capitanio D, Gelfi C, Ritelli M, Colombi M (2021) Matrix metalloproteinases inhibition by doxycycline rescues extracellular matrix organization and partly reverts myofibroblast differentiation in hypermobile Ehlers-Danlos syndrome dermal fibroblasts: A potential therapeutic target? Cells 10:3236","journal-title":"Cells"},{"key":"2156_CR58","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12640-009-9078-1","volume":"16","author":"Y Cho","year":"2009","unstructured":"Cho Y, Son HJ, Kim EM, Choi JH, Kim ST, Ji IJ, Choi DH, Joh TH, Kim YS, Hwang O (2009) Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3. Neurotox Res 16:361\u2013371","journal-title":"Neurotox Res"},{"issue":"11","key":"2156_CR59","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/mds.27077","volume":"32","author":"T Chotibut","year":"2017","unstructured":"Chotibut T, Meadows S, Kasanga EA (2017) Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson\u2019s disease model. Mov Disord 32(11):1547\u20131556. https:\/\/doi.org\/10.1002\/mds.27077","journal-title":"Mov Disord"},{"key":"2156_CR60","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/370526","volume":"2013","author":"YC Chung","year":"2013","unstructured":"Chung YC, Kim YS, Bok E, Yune TY, Maeng S, Jin BK (2013) MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson\u2019s disease. Mediators Inflamm 2013:370526","journal-title":"Mediators Inflamm"},{"key":"2156_CR61","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.3390\/ijms19124078","volume":"19","author":"DL Clemens","year":"2018","unstructured":"Clemens DL, Duryee MJ, Sarmiento C, Chiou A, McGowan JD, Hunter CD, Schlichte SL, Tian J, Klassen LW, O\u2019Dell JR, Thiele GM, Mikuls TR, Zimmerman MC, Anderson DR (2018) Novel antioxidant properties of doxycycline. Int J Mol Sci 19:4078","journal-title":"Int J Mol Sci"},{"key":"2156_CR62","doi-asserted-by":"publisher","first-page":"12120","DOI":"10.1073\/pnas.96.21.12120","volume":"96","author":"O Corti","year":"1999","unstructured":"Corti O, S\u00e1nchez-Capelo A, Colin P, Hanoun N, Hamon M, Mallet J (1999) Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 96:12120\u201312125","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2156_CR63","doi-asserted-by":"publisher","first-page":"41647","DOI":"10.1074\/jbc.M111.274548","volume":"286","author":"R Costa","year":"2011","unstructured":"Costa R, Speretta E, Crowther DC, Cardoso I (2011) Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease. J Biol Chem 286:41647\u201341655","journal-title":"J Biol Chem"},{"key":"2156_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ani12030262","volume":"12","author":"F De Santis","year":"2022","unstructured":"De Santis F, Boari A, Dondi F, Crisi PE (2022) Drug-dosing adjustment in dogs and cats with chronic kidney disease. Animals 12:262","journal-title":"Animals"},{"issue":"12","key":"2156_CR65","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1111\/j.0953-816X.2004.03372.x","volume":"19","author":"E Diguet","year":"2004","unstructured":"Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F (2004) Deleterious effects of minocycline in animal models of Parkinson\u2019s disease and Huntington\u2019s disease. Eur J Neurosci 19(12):3266\u20133276","journal-title":"Eur J Neurosci"},{"key":"2156_CR66","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00726-021-02966-0","volume":"53","author":"X Ding","year":"2021","unstructured":"Ding X, Bian D, Li W, Xie Y, Li X, Lv J, Tang R (2021) Host defense peptide LL-37 is involved in the regulation of cell proliferation and production of pro-inflammatory cytokines in hepatocellular carcinoma cells. Amino Acids 53:471\u2013484","journal-title":"Amino Acids"},{"key":"2156_CR68","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00210-023-02435-3","volume":"396","author":"L do Amaral","year":"2023","unstructured":"do Amaral L, dos Santos NAG, Sisti FM, Del Bel E, dos Santos AC (2023) Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins. Naunyn Schmiedebergs Arch Pharmacol 396:1787\u20131796","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2156_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105256","volume":"151","author":"A Dominguez-Meijide","year":"2021","unstructured":"Dominguez-Meijide A, Parrales V, Vasili E, Gonz\u00e1lez-Liz\u00e1rraga F, K\u00f6nig A, L\u00e1zaro DF, Lannuzel A, Haik S, Del Bel E, Cheh\u00edn R, Raisman-Vozari R, Michel PP, Bizat N, Outeiro TF (2021) Doxycycline inhibits \u03b1-synuclein-associated pathologies in vitro and in vivo. Neurobiol Dis 151:105256","journal-title":"Neurobiol Dis"},{"key":"2156_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1045465","volume":"13","author":"M dos Santos Pereira","year":"2022","unstructured":"dos Santos Pereira M, Nascimento GCd, Bortolanza M, Michel PP, Raisman-Vozari R, Del Bel E (2022) Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model. Front Pharmacol 13:1045465","journal-title":"Front Pharmacol"},{"key":"2156_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113015","volume":"142","author":"N Ebadpour","year":"2024","unstructured":"Ebadpour N, Mahmoudi M, Kheder RK, Abavisani M, Baridjavadi Z, Abdollahi N, Esmaeili S-A (2024) From mitochondrial dysfunction to neuroinflammation in Parkinson\u2019s disease: pathogenesis and mitochondrial therapeutic approaches. Int Immunopharmacol 142:113015","journal-title":"Int Immunopharmacol"},{"key":"2156_CR72","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3855\/jidc.16677","volume":"17","author":"K Eljaaly","year":"2023","unstructured":"Eljaaly K, Alghamdi H, Almehmadi H, Aljawi F, Hassan A, Thabit AK (2023) Long-term gastrointestinal adverse effects of doxycycline. J Infect Dev Ctries 17:281\u2013285","journal-title":"J Infect Dev Ctries"},{"key":"2156_CR73","first-page":"1328","volume":"23","author":"A Er","year":"2020","unstructured":"Er A, Coskun D, Bahcivan E, Dik B (2020) Effect of doxycycline and meloxicam on cytokines, brain-derived neurotrophic factor, matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-3 and cyclooxygenase-2 in brain. Iran J Basic Med Sci 23:1328\u20131334","journal-title":"Iran J Basic Med Sci"},{"key":"2156_CR74","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/JEP.S265282","volume":"13","author":"A Fabbrini","year":"2021","unstructured":"Fabbrini A, Guerra A (2021) Pathophysiological mechanisms and experimental pharmacotherapy for L-Dopa-induced dyskinesia. J Exp Pharmacol 13:469\u2013485","journal-title":"J Exp Pharmacol"},{"key":"2156_CR75","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/cells10082163","volume":"10","author":"NC Ferreira Junior","year":"2021","unstructured":"Ferreira Junior NC, Dos Santos PM, Francis N, Ramirez P, Martorell P, Gonz\u00e1lez-Lizarraga F, Figad\u00e8re B, Chehin R, Del Bel E, Raisman-Vozari R, Michel PP (2021) The chemically-modified tetracycline COL-3 and its parent compound doxycycline prevent microglial inflammatory responses by reducing glucose-mediated oxidative stress. Cells 10:2163","journal-title":"Cells"},{"key":"2156_CR76","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jpsychires.2013.06.008","volume":"47","author":"BS Ferreira Mello","year":"2013","unstructured":"Ferreira Mello BS, Monte AS, McIntyre RS, Soczynska JK, Cust\u00f3dio CS, Cordeiro RC, Chaves JH, Mendes Vasconcelos SM, Nobre J\u00fanior HV, Floren\u00e7o de Sousa FC, Hyphantis TN, Carvalho AF, Mac\u00eado DS (2013) Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. J Psychiatr Res 47:1521\u20131529","journal-title":"J Psychiatr Res"},{"key":"2156_CR77","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00441-023-03806-1","volume":"393","author":"X Geng","year":"2023","unstructured":"Geng X, Zou Y, Li J, Li S, Qi R, Yu H, Zhong L (2023) BDNF alleviates Parkinson\u2019s disease by promoting STAT3 phosphorylation and regulating neuronal autophagy. Cell Tissue Res 393:455\u2013470","journal-title":"Cell Tissue Res"},{"key":"2156_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.108999","volume":"209","author":"V Gomez-Murcia","year":"2022","unstructured":"Gomez-Murcia V, Carvalho K, Thiroux B, Caillierez R, Besegher M, Sergeant N, Bu\u00e9e L, Faivre E, Blum D (2022) Impact of chronic doxycycline treatment in the APP\/PS1 mouse model of Alzheimer\u2019s disease. Neuropharmacology 209:108999","journal-title":"Neuropharmacology"},{"key":"2156_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-020-00128-6","volume":"10","author":"AC Hadjimichael","year":"2020","unstructured":"Hadjimichael AC, Foukas AF, Savvidou OD, Mavrogenis AF, Psyrri AK, Papagelopoulos PJ (2020) The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review. Clin Sarcoma Res 10:7","journal-title":"Clin Sarcoma Res"},{"key":"2156_CR80","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/jdv.14345","volume":"31","author":"M Henehan","year":"2017","unstructured":"Henehan M, Montuno M, De Benedetto A (2017) Doxycycline as an anti\u2010inflammatory agent: updates in dermatology. J Eur Acad Dermatol Venereol 31:1800\u20131808","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2156_CR81","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00702-022-02520-6","volume":"129","author":"M H\u00f6llerhage","year":"2022","unstructured":"H\u00f6llerhage M, Klietz M, H\u00f6glinger G (2022) Disease modification in Parkinsonism: obstacles and ways forward. J Neural Transm 129:1133\u20131153","journal-title":"J Neural Transm"},{"key":"2156_CR82","doi-asserted-by":"publisher","first-page":"10808","DOI":"10.3390\/ijms231810808","volume":"23","author":"M Huang","year":"2022","unstructured":"Huang M, Bargues-Carot A, Riaz Z, Wickham H, Zenitsky G, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2022) Impact of environmental risk factors on mitochondrial dysfunction, neuroinflammation, protein misfolding, and oxidative stress in the etiopathogenesis of Parkinson\u2019s disease. Int J Mol Sci 23:10808","journal-title":"Int J Mol Sci"},{"key":"2156_CR83","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cellimm.2010.05.005","volume":"264","author":"T Into","year":"2010","unstructured":"Into T, Inomata M, Shibata K, Murakami Y (2010) Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts. Cell Immunol 264:104\u2013109","journal-title":"Cell Immunol"},{"issue":"1","key":"2156_CR84","doi-asserted-by":"publisher","first-page":"17003","DOI":"10.1038\/s41598-021-96540-z","volume":"11","author":"EC Jenkins","year":"2021","unstructured":"Jenkins EC, O\u2019Connell MJ, Manfredi G, Germain D (2021) Doxycycline promotes proteasome fitness in the central nervous system. Sci Rep 11(1):17003","journal-title":"Sci Rep"},{"key":"2156_CR85","doi-asserted-by":"publisher","first-page":"253","DOI":"10.52711\/2321-5836.2022.00043","volume":"14","author":"R Jodh","year":"2022","unstructured":"Jodh R, Tawar M, Gomkale K, Jari S, Toply J, Faisal N (2022) An updated review on doxycycline. RJPPD 14:253\u2013256","journal-title":"RJPPD"},{"key":"2156_CR86","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/jid.2012.14","volume":"132","author":"KN Kanada","year":"2012","unstructured":"Kanada KN, Nakatsuji T, Gallo RL (2012) Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin. J Invest Dermatol 132:1435\u20131442","journal-title":"J Invest Dermatol"},{"key":"2156_CR87","first-page":"4391","volume":"14","author":"M Kandhwal","year":"2022","unstructured":"Kandhwal M, Behl T, Singh S, Sharma N, Arora S, Bhatia S, Al-Harrasi A, Sachdeva M, Bungau S (2022) Role of matrix metalloproteinase in wound healing. Am J Transl Res 14:4391\u20134405","journal-title":"Am J Transl Res"},{"key":"2156_CR88","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.contraception.2011.08.006","volume":"85","author":"B Kaneshiro","year":"2012","unstructured":"Kaneshiro B, Edelman A, Carlson NE, Nichols M, Forbes MM, Jensen J (2012) A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use. Contraception 85:351\u2013358","journal-title":"Contraception"},{"key":"2156_CR89","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","volume":"24","author":"GH Kim","year":"2015","unstructured":"Kim GH, Kim JE, Rhie SJ, Yoon S (2015) The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol 24:325\u2013340","journal-title":"Exp Neurobiol"},{"key":"2156_CR90","first-page":"92","volume":"14","author":"SN Kondaveeti","year":"2024","unstructured":"Kondaveeti SN, Thummuru ES, Thekkekkara D, Narayanan TL, Tausif YM, Srivalli Ch MR, Babu A (2024) Therapeutic potential of Simvastatin and Doxycycline combination for Alzheimer\u2019s disease. J App Pharm Sci 14:92\u201398","journal-title":"J App Pharm Sci"},{"issue":"s2","key":"2156_CR91","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.3233\/JPD-212673","volume":"11","author":"V Kovaleva","year":"2021","unstructured":"Kovaleva V, Saarma M (2021) Endoplasmic reticulum stress regulators: new drug targets for Parkinson\u2019s disease. J Parkinson\u2019s Dis 11(s2):S219\u2013S228","journal-title":"J Parkinson\u2019s Dis"},{"key":"2156_CR92","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biomedicines9080918","volume":"9","author":"H-C Kung","year":"2021","unstructured":"Kung H-C, Lin K-J, Kung C-T, Lin T-K (2021) Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson\u2019s disease. Biomedicines 9:918","journal-title":"Biomedicines"},{"key":"2156_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.105229","volume":"106","author":"P La Vitola","year":"2023","unstructured":"La Vitola P, Artioli L, Cerovic M, Poletto C, Dacomo L, Leva S, Balducci C, Forloni G (2023) Repositioning doxycycline for treating synucleinopathies: evidence from a pre-clinical mouse model. Parkinsonism Relat Disord 106:105229","journal-title":"Parkinsonism Relat Disord"},{"key":"2156_CR94","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ejphar.2010.07.010","volume":"644","author":"HC Lai","year":"2010","unstructured":"Lai HC, Yeh YC, Ting CT, Lee WL, Lee HW, Wang LC, Wang KY, Lai HC, Wu A, Liu TJ (2010) Doxycycline suppresses doxorubicin-induced oxidative stress and cellular apoptosis in mouse hearts. Eur J Pharmacol 644:176\u2013187","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"2156_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039359","volume":"7","author":"IM Larr\u00e1yoz","year":"2012","unstructured":"Larr\u00e1yoz IM, de Luis A, R\u00faa O, Velilla S, Cabello J, Mart\u00ednez A (2012) Molecular effects of doxycycline treatment on pterygium as revealed by massive transcriptome sequencing. PLoS ONE 7(6):e39359","journal-title":"PLoS ONE"},{"key":"2156_CR96","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/glia.22496","volume":"61","author":"M Lazzarini","year":"2013","unstructured":"Lazzarini M, Martin S, Mitkovski M, Vozari RR, St\u00fchmer W, Bel ED (2013) Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model. Glia 61:1084\u20131100","journal-title":"Glia"},{"key":"2156_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810546","author":"HS Lee","year":"2022","unstructured":"Lee HS, Kim WJ (2022) The role of matrix metalloproteinase in inflammation with a focus on infectious diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231810546","journal-title":"Int J Mol Sci"},{"key":"2156_CR98","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/imj.12179","volume":"43","author":"T Lee","year":"2013","unstructured":"Lee T, Russell L, Deng M, Gibson PR (2013) Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in A ustralians deployed abroad. Intern Med J 43:919\u2013926","journal-title":"Intern Med J"},{"key":"2156_CR99","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bcp.2015.02.003","volume":"94","author":"M Lee","year":"2015","unstructured":"Lee M, Shi X, Barron AE, McGeer E, McGeer PL (2015) Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation. Biochem Pharmacol 94:130\u2013141","journal-title":"Biochem Pharmacol"},{"key":"2156_CR100","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.tins.2024.09.001","volume":"47","author":"S Lee","year":"2024","unstructured":"Lee S, Silverman N, Gao F-B (2024) Emerging roles of antimicrobial peptides in innate immunity, neuronal function, and neurodegeneration. Trends Neurosci 47:949\u2013961","journal-title":"Trends Neurosci"},{"key":"2156_CR101","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/biom15060864","volume":"15","author":"K Lin","year":"2025","unstructured":"Lin K, Wang R, Li T, Zuo Y, Yang S, Dong D, Zhu Y (2025) Drug transporters and metabolizing enzymes in antimicrobial drug pharmacokinetics: mechanisms, drug-drug interactions, and clinical implications. Biomolecules 15:864","journal-title":"Biomolecules"},{"key":"2156_CR102","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2525967","volume":"2017","author":"Z Liu","year":"2017","unstructured":"Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L (2017) Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid Med Cell Longev 2017:2525967","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"2156_CR103","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41419-021-03945-9","volume":"12","author":"C Lopez-Crisosto","year":"2021","unstructured":"Lopez-Crisosto C, D\u00edaz-Vegas A, Castro PF, Rothermel BA, Bravo-Sagua R, Lavandero S (2021) Endoplasmic reticulum\u2212 mitochondria coupling increases during doxycycline-induced mitochondrial stress in HeLa cells. Cell Death Dis 12(7):657","journal-title":"Cell Death Dis"},{"key":"2156_CR104","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00210-021-02188-x","volume":"395","author":"ER Lopez-Navarro","year":"2022","unstructured":"Lopez-Navarro ER, Gutierrez J (2022) Metalloproteinases and their inhibitors in neurological disease. Naunyn Schmiedebergs Arch Pharmacol 395:27\u201338","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2156_CR105","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0197-0186(03)00004-4","volume":"43","author":"S Lorenzl","year":"2003","unstructured":"Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, Cudkowicz ME, Beal MF (2003) Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer\u2019s disease. Neurochem Int 43:191\u2013196","journal-title":"Neurochem Int"},{"key":"2156_CR106","doi-asserted-by":"publisher","DOI":"10.1177\/20406223211024362","volume":"12","author":"NO Mansour","year":"2021","unstructured":"Mansour NO, Shama MA, Werida RH (2021) The effect of doxycycline on neuron-specific enolase in patients with traumatic brain injury: a randomized controlled trial. Ther Adv Chronic Dis 12:20406223211024362","journal-title":"Ther Adv Chronic Dis"},{"key":"2156_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577672","volume":"359","author":"S Marjani","year":"2021","unstructured":"Marjani S, Zirh S, Sever-Bahcekapili M, Cakir-Aktas C, Muftuoglu SF, Mut M (2021) Doxycycline alleviates acute traumatic brain injury by suppressing neuroinflammation and apoptosis in a mouse model. J Neuroimmunol 359:577672","journal-title":"J Neuroimmunol"},{"key":"2156_CR108","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00702-021-02457-2","volume":"129","author":"I Markulin","year":"2022","unstructured":"Markulin I, Matasin M, Turk VE, Salkovi\u0107-Petrisic M (2022) Challenges of repurposing tetracyclines for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease. J Neural Transm 129:773\u2013804","journal-title":"J Neural Transm"},{"key":"2156_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s11274-023-03545-z","volume":"39","author":"H Memariani","year":"2023","unstructured":"Memariani H, Memariani M (2023) Antibiofilm properties of cathelicidin LL-37: an in-depth review. World J Microbiol Biotechnol 39:99","journal-title":"World J Microbiol Biotechnol"},{"key":"2156_CR110","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-024-10099-w","volume":"19","author":"SAA Morsy","year":"2024","unstructured":"Morsy SAA, Fathelbab MH, El-Sayed NS, El-Habashy SE, Aly RG, Harby SA (2024) Doxycycline-loaded calcium phosphate nanoparticles with a pectin coat can ameliorate lipopolysaccharide-induced neuroinflammation via enhancing AMPK. J Neuroimmune Pharmacol 19:2","journal-title":"J Neuroimmune Pharmacol"},{"key":"2156_CR111","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2169\/internalmedicine.8940-21","volume":"62","author":"H Murakami","year":"2023","unstructured":"Murakami H, Shiraishi T, Umehara T, Omoto S, Iguchi Y (2023) Recent advances in drug therapy for parkinson\u2019s disease. Intern Med 62:33\u201342","journal-title":"Intern Med"},{"issue":"Suppl 8","key":"2156_CR112","first-page":"S82","volume":"71","author":"MT Naji","year":"2021","unstructured":"Naji MT, Al-Kuraishy HM, Al-Gareeb AI (2021) Differential effects of statins on matrix metalloproteinase-9 (MMP-9) in patients with acute ischaemic stroke: a potential for salutary. JPMA J Pak Med Assoc 71(Suppl 8):S82-s87","journal-title":"JPMA J Pak Med Assoc"},{"key":"2156_CR113","doi-asserted-by":"publisher","first-page":"F1347","DOI":"10.1152\/ajprenal.00648.2017","volume":"315","author":"T Nakagawa","year":"2018","unstructured":"Nakagawa T, Kakizoe Y, Iwata Y, Miyasato Y, Mizumoto T, Adachi M, Izumi Y, Kuwabara T, Suenaga N, Narita Y (2018) Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects. Am J Physiol Renal Physiol 315:F1347\u2013F1357","journal-title":"Am J Physiol Renal Physiol"},{"key":"2156_CR114","doi-asserted-by":"publisher","DOI":"10.1177\/17590914231155976","volume":"15","author":"G Nascimento","year":"2023","unstructured":"Nascimento G, Bortolanza M, Bribian A, Leal-Luiz G, Raisman-Vozari R, L\u00f3pez-Mascaraque L, Del-Bel E (2023) Dynamic involvement of striatal NG2-glia in L-DOPA induced dyskinesia in Parkinsonian rats: effects of doxycycline. ASN Neuro 15:17590914231155976","journal-title":"ASN Neuro"},{"key":"2156_CR115","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/ijms20020257","volume":"20","author":"TKS Ng","year":"2019","unstructured":"Ng TKS, Ho CSH, Tam WWS, Kua EH, Ho RC (2019) Decreased serum brain-derived neurotrophic factor (BDNF) levels in patients with alzheimer\u2019s disease (AD): a systematic review and meta-analysis. Int J Mol Sci 20:257","journal-title":"Int J Mol Sci"},{"key":"2156_CR116","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.pbb.2011.02.025","volume":"98","author":"CRA Nogueira","year":"2011","unstructured":"Nogueira CRA, Damasceno FM, de Aquino-Neto MR, de Andra GM, Fontenele JB, de Meiros TA, Viana GSdB (2011) Doxycycline protects against pilocarpine-induced convulsions in rats, through its antioxidant effect and modulation of brain amino acids. Pharmacol Biochem Behav 98:525\u2013532","journal-title":"Pharmacol Biochem Behav"},{"key":"2156_CR117","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1128\/AAC.01650-12","volume":"57","author":"J Noore","year":"2013","unstructured":"Noore J, Noore A, Li B (2013) Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus. Antimicrob Agents Chemother 57:1283\u20131290","journal-title":"Antimicrob Agents Chemother"},{"key":"2156_CR118","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.expneurol.2012.07.018","volume":"237","author":"G N\u00fcbling","year":"2012","unstructured":"N\u00fcbling G, Levin J, Bader B, Israel L, B\u00f6tzel K, Lorenzl S, Giese A (2012) Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation. Exp Neurol 237:470\u2013476","journal-title":"Exp Neurol"},{"key":"2156_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031170","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G (2020) BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21031170","journal-title":"Int J Mol Sci"},{"key":"2156_CR120","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s12035-019-01847-8","volume":"57","author":"E Paldino","year":"2020","unstructured":"Paldino E, Balducci C, La Vitola P, Artioli L, D\u2019Angelo V, Giamp\u00e0 C, Artuso V, Forloni G, Fusco FR (2020) Neuroprotective effects of doxycycline in the R6\/2 mouse model of Huntington\u2019s disease. Mol Neurobiol 57:1889\u20131903","journal-title":"Mol Neurobiol"},{"key":"2156_CR121","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jvp.13111","volume":"46","author":"FR Portugal","year":"2023","unstructured":"Portugal FR, Lacroix MZ, Roques BB, Gayrard V, Toutain PL, Bousquet-M\u00e9lou A (2023) Doxycycline serum protein binding in pigs reveals a relatively high free fraction. J Vet Pharmacol Ther 46:112\u2013118","journal-title":"J Vet Pharmacol Ther"},{"key":"2156_CR122","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s12035-024-04315-0","volume":"62","author":"D Radosinska","year":"2025","unstructured":"Radosinska D, Radosinska J (2025) The link between matrix metalloproteinases and Alzheimer\u2019s disease pathophysiology. Mol Neurobiol 62:885\u2013899","journal-title":"Mol Neurobiol"},{"key":"2156_CR123","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.33263\/BRIAC106.71357151","volume":"10","author":"MM Rahman","year":"2020","unstructured":"Rahman MM, Ferdous KS, Ahmed M (2020) Emerging promise of nanoparticle-based treatment for Parkinson\u2019s disease. Biointerface Res Appl Chem 10:7135\u20137151","journal-title":"Biointerface Res Appl Chem"},{"key":"2156_CR124","unstructured":"Rai SN (2024) editor. Recent advances in the treatment of neurodegenerative disorders"},{"key":"2156_CR125","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/02699052.2020.1772508","volume":"34","author":"A Rana","year":"2020","unstructured":"Rana A, Singh S, Deshmukh R, Kumar A (2020) Pharmacological potential of tocopherol and doxycycline against traumatic brain injury-induced cognitive\/motor impairment in rats. Brain Inj 34:1039\u20131050","journal-title":"Brain Inj"},{"issue":"4","key":"2156_CR126","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/japtr.JAPTR_65_19","volume":"10","author":"HA Rasheed","year":"2019","unstructured":"Rasheed HA, Al-Kuraishy HM, Al-Gareeb AI, Hussien NR, Al-Nami MS (2019) Effects of diabetic pharmacotherapy on prolactin hormone in patients with type 2 diabetes mellitus: bane or Boon. J Adv Pharm Technol Res 10(4):163\u2013168","journal-title":"J Adv Pharm Technol Res"},{"issue":"13","key":"2156_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.691881","volume":"3","author":"H Ren","year":"2021","unstructured":"Ren H, Zhai W, Lu X, Wang G (2021) The cross-links of endoplasmic reticulum stress, autophagy, and neurodegeneration in Parkinson\u2019s disease. Front Aging Neurosci 3(13):691881","journal-title":"Front Aging Neurosci"},{"key":"2156_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201606623","volume":"27","author":"M Riool","year":"2017","unstructured":"Riool M, de Breij A, de Boer L, Kwakman PHS, Cordfunke RA, Cohen O, Malanovic N, Emanuel N, Lohner K, Drijfhout JW, Nibbering PH, Zaat SAJ (2017) Controlled release of LL-37-derived synthetic antimicrobial and anti-biofilm peptides SAAP-145 and SAAP-276 prevents experimental biomaterial-associated Staphylococcus aureus infection. Adv Funct Mater 27:1606623","journal-title":"Adv Funct Mater"},{"key":"2156_CR129","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1038\/s41598-022-09394-4","volume":"12","author":"BD Robinson","year":"2022","unstructured":"Robinson BD, Isbell CL, Melge AR, Lomas AM, Shaji CA, Mohan CG, Huang JH, Tharakan B (2022) Doxycycline prevents blood\u2013brain barrier dysfunction and microvascular hyperpermeability after traumatic brain injury. Sci Rep 12:5415","journal-title":"Sci Rep"},{"key":"2156_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300597","volume":"19","author":"C Rose","year":"2024","unstructured":"Rose C, Tomas-Grau RH, Zabala B, Michel PP, Brunel JM, Cheh\u00edn R, Raisman-Vozari R, Ferri\u00e9 L, Figad\u00e8re B (2024) C9-functionalized doxycycline analogs as drug candidates to prevent pathological \u03b1-synuclein aggregation and neuroinflammation in Parkinson\u2019s disease degeneration. ChemMedChem 19:e202300597","journal-title":"ChemMedChem"},{"key":"2156_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052793","author":"Z Ruan","year":"2022","unstructured":"Ruan Z, Zhang D, Huang R, Sun W, Hou L, Zhao J, Wang Q (2022) Microglial activation damages dopaminergic neurons through MMP-2\/-9-mediated increase of blood-brain barrier permeability in a Parkinson\u2019s disease mouse model. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23052793","journal-title":"Int J Mol Sci"},{"key":"2156_CR132","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.2147\/DDDT.S187842","volume":"13","author":"M Saeed","year":"2019","unstructured":"Saeed M, Arun MZ, Guzeloglu M, Onursal C, Gokce G, Korkmaz CG, Reel B (2019) Low-dose doxycycline inhibits hydrogen peroxide-induced oxidative stress, MMP-2 up-regulation and contractile dysfunction in human saphenous vein grafts. Drug des Devel Ther 13:1791\u20131801","journal-title":"Drug des Devel Ther"},{"key":"2156_CR133","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","volume":"29","author":"FV Santa-Cec\u00edlia","year":"2016","unstructured":"Santa-Cec\u00edlia FV, Socias B, Ouidja MO, Sepulveda-Diaz JE, Acu\u00f1a L, Silva RL, Michel PP, Del-Bel E, Cunha TM, Raisman-Vozari R (2016) Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways. Neurotox Res 29:447\u2013459","journal-title":"Neurotox Res"},{"key":"2156_CR134","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s12640-019-00015-z","volume":"35","author":"FV Santa-Cec\u00edlia","year":"2019","unstructured":"Santa-Cec\u00edlia FV, Leite CA, Del-Bel E, Raisman-Vozari R (2019) The neuroprotective effect of doxycycline on neurodegenerative diseases. Neurotox Res 35:981\u2013986","journal-title":"Neurotox Res"},{"key":"2156_CR135","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1055\/s-0043-1768668","volume":"81","author":"BL Santos-Lobato","year":"2023","unstructured":"Santos-Lobato BL, Brito M, Pimentel \u00c2V, Cavalcanti RTO, Del-Bel E, Tumas V (2023) Doxycycline to treat levodopa-induced dyskinesias in Parkinson\u2019s disease: a preliminary study. Arq Neuropsiquiatr 81:460\u2013468","journal-title":"Arq Neuropsiquiatr"},{"issue":"839","key":"2156_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.156379","volume":"15","author":"J Shan","year":"2022","unstructured":"Shan J, Xiaoqian D, Xia L, Yu W, Zhilong Z, Zhihui S, Yanjie Q (2022) Oxidative stress, autophagy, and apoptosis induced by doxycycline in loach fin cells in vitro. Sci Total Environ 15(839):156379","journal-title":"Sci Total Environ"},{"key":"2156_CR137","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10571-017-0545-6","volume":"38","author":"GT Shishkina","year":"2018","unstructured":"Shishkina GT, Lanshakov DA, Bannova AV, Kalinina TS, Agarina NP, Dygalo NN (2018) Doxycycline used for control of transgene expression has its own effects on behaviors and Bcl-xL in the rat hippocampus. Cell Mol Neurobiol 38:281\u2013288","journal-title":"Cell Mol Neurobiol"},{"key":"2156_CR138","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","volume":"86","author":"H Sies","year":"2017","unstructured":"Sies H, Berndt C, Jones DP (2017) Oxidative stress. Annu Rev Biochem 86:715\u2013748","journal-title":"Annu Rev Biochem"},{"key":"2156_CR139","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1080\/00207454.2022.2154670","volume":"134","author":"S Singh","year":"2024","unstructured":"Singh S, Chauhan K (2024) Pharmacological approach using doxycycline and tocopherol in rotenone induced oxidative stress, neuroinflammation and Parkinson\u2019s like symptoms. Int J Neurosci 134:866\u2013881","journal-title":"Int J Neurosci"},{"key":"2156_CR140","first-page":"1046","volume":"14","author":"S Singh","year":"2021","unstructured":"Singh S, Khanna D, Kalra S (2021) Minocycline and doxycycline: more than antibiotics. Curr Mol Med 14:1046\u20131065","journal-title":"Curr Mol Med"},{"key":"2156_CR141","volume-title":"Synaptic plasticity in neurodegenerative disorders","year":"2024","unstructured":"Singh S, Rai SN, Singh SK (eds) (2024) Synaptic plasticity in neurodegenerative disorders. CRC Press, Boca Raton"},{"key":"2156_CR142","unstructured":"Singh AK, Rai SN (2025) Rejuvenating the brain: nutraceuticals, autophagy, and longevity"},{"issue":"10","key":"2156_CR143","first-page":"3995","volume":"29","author":"K Son","year":"2009","unstructured":"Son K, Fujioka S, Iida T, Furukawa K, Fujita T, Yamada H, Chiao PJ, Yanaga K (2009) Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells. Anticancer Res 29(10):3995\u20134003","journal-title":"Anticancer Res"},{"issue":"6","key":"2156_CR144","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2174\/1381612043453162","volume":"10","author":"M Thomas","year":"2004","unstructured":"Thomas M, Le WD (2004) Minocycline: neuroprotective mechanisms in Parkinson\u2019s disease. Curr Pharm des 10(6):679\u2013686. https:\/\/doi.org\/10.2174\/1381612043453162","journal-title":"Curr Pharm des"},{"key":"2156_CR145","first-page":"575","volume":"12","author":"A Tourville","year":"2023","unstructured":"Tourville A, Viguier S, Gonz\u00e1lez-Liz\u00e1rraga F, Tomas-Grau RH, Ramirez P, Brunel JM, Dos Santos PM, Del-Bel E, Chehin R, Ferri\u00e9 L, Raisman-Vozari R, Figad\u00e8re B, Michel PP (2023) Rescue of dopamine neurons from iron-dependent ferroptosis by doxycycline and demeclocycline and their non-antibiotic derivatives. Antioxidants (Basel, Switzerland) 12:575","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"2156_CR146","doi-asserted-by":"publisher","DOI":"10.1177\/11795735241247810","volume":"16","author":"A Turkistani","year":"2024","unstructured":"Turkistani A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Elhussieny O, Al-Farga A, Aqlan F, Saad HM, Batiha GE (2024a) The functional and molecular roles of p75 neurotrophin receptor (p75(NTR)) in epilepsy. J Cent Nerv Syst Dis 16:11795735241247810","journal-title":"J Cent Nerv Syst Dis"},{"key":"2156_CR147","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12640-024-00716-0","volume":"42","author":"A Turkistani","year":"2024","unstructured":"Turkistani A, Al-Kuraishy HM, Al-Gareeb AI, Negm WA, Bahaa MM, Metawee ME, El-Saber Batiha G (2024b) Blunted melatonin circadian rhythm in Parkinson\u2019s disease: express bewilderment. Neurotox Res 42:38","journal-title":"Neurotox Res"},{"key":"2156_CR148","volume":"2014","author":"X-X Wang","year":"2014","unstructured":"Wang X-X, Tan M-S, Yu J-T, Tan L (2014) Matrix metalloproteinases and their multiple roles in Alzheimer\u2019s disease. Biomed Res Int 2014:908636","journal-title":"Biomed Res Int"},{"issue":"14","key":"2156_CR149","doi-asserted-by":"publisher","first-page":"1288894","DOI":"10.3389\/fphar.2023.1288894","volume":"10","author":"D Wang","year":"2023","unstructured":"Wang D, Qu S, Zhang Z, Tan L, Chen X, Zhong HJ, Chong CM (2023) Strategies targeting endoplasmic reticulum stress to improve Parkinson\u2019s disease. Front Pharmacol 10(14):1288894","journal-title":"Front Pharmacol"},{"key":"2156_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/nu14020284","author":"JH White","year":"2022","unstructured":"White JH (2022) Emerging roles of vitamin D-induced antimicrobial peptides in antiviral innate immunity. Nutrients. https:\/\/doi.org\/10.3390\/nu14020284","journal-title":"Nutrients"},{"issue":"17","key":"2156_CR151","doi-asserted-by":"publisher","first-page":"1568500","DOI":"10.3389\/fnagi.2025.1568500","volume":"19","author":"J Won","year":"2025","unstructured":"Won J, Gogniat MA, Kurazumi T, Nielson KA (2025) Midlife brain health: understanding brain aging in middle-age and effects of interventions to prevent neurodegeneration in late life. Front Aging Neurosci 19(17):1568500","journal-title":"Front Aging Neurosci"},{"key":"2156_CR152","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/ani13081293","volume":"13","author":"J Xu","year":"2023","unstructured":"Xu J, Liang J, Chen W, Wen X, Zhang N, Ma B, Zou Y, Mi J, Wang Y, Liao X (2023) Doxycycline attenuates pig intestinal microbial interactions and changes microbial metabolic pathways. Animals 13:1293","journal-title":"Animals"},{"issue":"2","key":"2156_CR153","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jnr.10709","volume":"74","author":"L Yang","year":"2003","unstructured":"Yang L, Sugama S, Chirichigno JW et al (2003) Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 74(2):278\u2013285. https:\/\/doi.org\/10.1002\/jnr.10709","journal-title":"J Neurosci Res"},{"key":"2156_CR154","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.bcp.2007.06.031","volume":"74","author":"YC Yeh","year":"2007","unstructured":"Yeh YC, Lai HC, Ting CT, Lee WL, Wang LC, Wang KY, Lai HC, Liu TJ (2007) Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol 74:969\u2013980","journal-title":"Biochem Pharmacol"},{"key":"2156_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2015.11.032","volume":"103","author":"R Yu","year":"2016","unstructured":"Yu R, Zheng L, Cui Y, Zhang H, Ye H (2016) Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1. Neuropharmacology 103:1\u201315","journal-title":"Neuropharmacology"},{"key":"2156_CR156","first-page":"3468","volume":"19","author":"GB Zhang","year":"2015","unstructured":"Zhang GB, Feng YH, Wang PQ, Song JH, Wang P, Wang SA (2015) A study on the protective role of doxycycline upon dopaminergic neuron of LPS-PD rat model rat. Eur Rev Med Pharmacol Sci 19:3468\u20133474","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2156_CR157","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3233\/JAD-230007","volume":"93","author":"LY Zhang","year":"2023","unstructured":"Zhang LY, Wang DZ, Wang J, Guo L, Li BH, Wang JH (2023) Associations of serum antimicrobial peptide LL-37 with longitudinal cognitive decline and neurodegeneration among older adults with memory complaints. J Alzheimers Dis 93:595\u2013603","journal-title":"J Alzheimers Dis"},{"key":"2156_CR158","volume":"10","author":"J Zhou","year":"2025","unstructured":"Zhou J, Meng F, Li Q, Wang H, Zou N (2025) Subchronic exposure to T-2 toxin triggered neurobehavioral damage in developing juvenile rats was associated with oxidative stress and mitochondrial pathway-induced apoptosis of hippocampal neurons. Chem Biol Interact 10:111824","journal-title":"Chem Biol Interact"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02156-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:03:40Z","timestamp":1778861020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02156-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":159,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2156"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02156-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}